These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1349 related items for PubMed ID: 33118032

  • 1. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
    Galiano-Landeira J, Torra A, Vila M, Bové J.
    Brain; 2020 Dec 01; 143(12):3717-3733. PubMed ID: 33118032
    [Abstract] [Full Text] [Related]

  • 2. Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.
    Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ, Netherlands Brain Bank, Rozemuller AJ, van de Berg WD.
    Mov Disord; 2014 Sep 01; 29(10):1244-51. PubMed ID: 24996051
    [Abstract] [Full Text] [Related]

  • 3. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.
    Brain; 2005 Nov 01; 128(Pt 11):2654-64. PubMed ID: 16000336
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The center of olfactory bulb-seeded α-synucleinopathy is the limbic system and the ensuing pathology is higher in male than in female mice.
    Mason DM, Wang Y, Bhatia TN, Miner KM, Trbojevic SA, Stolz JF, Luk KC, Leak RK.
    Brain Pathol; 2019 Nov 01; 29(6):741-770. PubMed ID: 30854742
    [Abstract] [Full Text] [Related]

  • 6. Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain.
    Thakur P, Breger LS, Lundblad M, Wan OW, Mattsson B, Luk KC, Lee VMY, Trojanowski JQ, Björklund A.
    Proc Natl Acad Sci U S A; 2017 Sep 26; 114(39):E8284-E8293. PubMed ID: 28900002
    [Abstract] [Full Text] [Related]

  • 7. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.
    Subbarayan MS, Hudson C, Moss LD, Nash KR, Bickford PC.
    J Neuroinflammation; 2020 Aug 15; 17(1):242. PubMed ID: 32799878
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H.
    J Neurochem; 2004 Oct 15; 91(2):451-61. PubMed ID: 15447678
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
    Orr CF, Rowe DB, Mizuno Y, Mori H, Halliday GM.
    Brain; 2005 Nov 15; 128(Pt 11):2665-74. PubMed ID: 16219675
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies.
    Chopra A, Outeiro TF.
    Brain; 2024 Jan 04; 147(1):81-90. PubMed ID: 37526295
    [Abstract] [Full Text] [Related]

  • 15. Fragmentation of Golgi apparatus of nigral neurons with alpha-synuclein-positive inclusions in patients with Parkinson's disease.
    Fujita Y, Ohama E, Takatama M, Al-Sarraj S, Okamoto K.
    Acta Neuropathol; 2006 Sep 04; 112(3):261-5. PubMed ID: 16855830
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y.
    Brain; 2010 Jan 04; 133(Pt 1):172-88. PubMed ID: 19903734
    [Abstract] [Full Text] [Related]

  • 20. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.
    Oliveras-Salvá M, Van der Perren A, Casadei N, Stroobants S, Nuber S, D'Hooge R, Van den Haute C, Baekelandt V.
    Mol Neurodegener; 2013 Nov 25; 8():44. PubMed ID: 24267638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.